P&G Manages Production Demands 'Day To Day' As Consumer Health Brands Drive Growth In Pandemic
P&G reported personal health care brands drove overall health care organic sales up 9% to $2.26bn in its latest quarter. CFO Jon Moeller says consumer stockpiling caused production acceleration as its five largest North American plants in March increased production 22% over monthly average for previous year.
You may also be interested in...
Macro factors that could hamper results include the economic recession caused by businesses’ reactions to novel coronavirus pandemic, the impact of COVID-19 on consumer buying trends and disruptions to supply chains.
"With all the positive things, I'd normally be raising guidance right now," says CEO Murray Kessler as Perrigo reports first-quarter results. But manufacturing operations aren't normal, and neither is the consumer health product marketplace.
Church & Dwight invests in two manufacturing plants to increase production of its vitafusion and L’il Critters gummies after COVID-19-related stockpiling clears many customers' inventories. Demand for the products and nasal hygiene helped drive 10.2% domestic consumer sales increase in the first quarter.